Clinical Trial Update: Investigate Risperidone for the Treatment of Schizophrenia in Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating risperidone for the treatment of schizophrenia in adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED